National Research Corporation

NASDAQ:NRC

Medical - Healthcare Information Services

Healthcare
$26.16 +0.40%

+$0.07 today

Market cap
$555.16M
Beta
0.40
P/E (TTM)
43.0
EPS (TTM)
$0.41
Dividend yield
3.14%
52W Low $11.01High $22.79

Volume 0.09M

Average 0.11M

NRC Minority Interest

The portion of consolidated subsidiaries' equity owned by outside shareholders.

National Research CorporationNASDAQ: NRC

Minority Interest · Q1 FY2026 · quarter ended Mar 2026

Minority interest remains negative

Q1 FY2026 minority interest was $0, compared with $0 a year earlier.

Context

  • Minority interest amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Minority interest increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoMar 2025
$0— since
Minority Interest past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Minority Interest history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Minority Interest vs competitors

How NRC compares with its peers on the latest reported figures

  • NRC's Mar 2026 minority interest of $0 is the 3rd highest of the 8 companies compared; the peer median is $0.
  • Minority interest amounts to 0.0% of total assets for NRC, versus a peer median of 0.0%.
NRC Competitors Peer median
Minority Interest for NRC and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
DHDefinitive Healthcare Corp.Mar 2026$44.47M -60.7%-43.2%8.6%
CTEVClaritev CorporationMar 2026$6.73M ——0.1%
NRCNational Research CorporationMar 2026$0 ——0.0%
HSTMHealthStream, Inc.Mar 2026$0 ——0.0%
PHRPhreesia, Inc.Apr 2026$0 ——0.0%
SOPHSOPHiA GENETICS S.A.Mar 2026$0 ——0.0%
HCATHealth Catalyst, Inc.Mar 2026$0 ——0.0%
CCLDCareCloud, Inc.Mar 2026$0 ——0.0%
Peer median (excluding NRC) $0-60.7%-43.2%0.0%

Competitors are the stored peer set for NRC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents54.36M25.03M6.65M4.23M4.14M
Short-term Investments00000
Net Receivables14.58M15.3M12.62M11.2M11.64M
Inventory00000
Other Current Assets883K1.01M856K692K520K
Total Current Assets73.71M43.72M24.36M19.6M20.21M
Property, Plant & Equipment (Net)13.37M17.8M30.27M39.9M40.47M
Goodwill61.61M61.61M61.61M66.15M66.15M
Intangible Assets1.79M1.61M1.47M2.62M2.23M
Long-term Investments0001.3M0
Tax Assets14K14K000
Other Non-current Assets7.05M5.7M4.73M2.98M5.82M
Total Non-current Assets83.83M86.75M98.08M112.94M114.67M
Total Assets157.54M130.46M122.44M132.54M134.88M
Account Payables1.94M1.15M1.3M1.19M4.07M
Short-term Debt5.24M5.32M7.82M4.79M4.01M
Tax Payables00222K353K0
Deferred Revenue17.21M15.2M14.83M15.79M16.2M
Other Current Liabilities8.85M7.19M8.08M541K5.12M
Total Current Liabilities40.39M33.42M36.2M35.86M36.62M
Long-term Debt22.27M17.69M29.47M57.9M75.02M
Deferred Tax Liabilities7M5.27M4.14M3.53M5.98M
Deferred Revenue (Non-current)000216K0
Other Non-current Liabilities1.38M1.67M2M2.59M3.26M
Total Non-current Liabilities31.82M25.01M37.28M65.4M84.27M
Total Liabilities72.2M58.43M73.48M101.26M120.89M
Common Stock31K31K31K31K32K
Retained Earnings(36.11M)(25.18M)(30.53M)(17.06M)(17.3M)
Accumulated OCI(2.38M)0000
Other Stockholders Equity00000
Minority Interest00000
Total Equity85.34M72.03M48.96M31.28M13.99M
Total Debt28.68M23.39M38.96M64.41M79.04M
Net Debt(25.68M)(1.64M)32.3M60.18M74.9M

National Research Corporation

NASDAQ:NRC

Intrinsic Alpha fair value

Locked

Current Price

$26.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.